GO:0045806 negative regulation of endocytosis: Cellular Trafficking Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0045806 (negative regulation of endocytosis) describes any process that stops, prevents, or reduces the frequency, rate or extent of endocytosis, the major route by which cells internalize receptors, nutrients and signaling molecules.
• Negative regulation of endocytosis is essential for controlling the duration and intensity of cell-surface receptor signaling, including receptor tyrosine kinases, JAK-STAT and T cell receptor pathways.
• Key molecular brakes include membrane-proximal N-terminal residues of cargo proteins, oxygen-sensing hydroxylation pathways, ubiquitin-ligase adaptors such as c-Cbl, and endocytic adaptor proteins such as Dab2.
• Dysregulated negative regulation of endocytosis contributes to cancer, metabolic disease, immune disorders and altered angiogenesis, making it a target for mechanistic and therapeutic studies.
• CRISPR knockout, point-mutation, knock-in and overexpression models allow causal testing of candidate negative regulators of endocytosis in relevant cell types.
• Combining CRISPR screening with imaging, proteomics and transcriptomics is a powerful strategy to map the negative-regulatory network of endocytosis.
Description
Endocytosis is the fundamental process by which cells internalize plasma membrane components, receptors, nutrients and extracellular fluid. Because excessive or prolonged endocytosis can deplete surface receptors and distort signaling, cells have evolved dedicated mechanisms that stop, prevent or reduce endocytosis. These mechanisms are collectively annotated under the Gene Ontology term GO:0045806, negative regulation of endocytosis. The term covers any process that decreases the frequency, rate or extent of endocytosis, and it is therefore central to understanding how cells tune receptor availability and signaling output. For researchers, GO:0045806 is not a single molecular event but a regulatory node that integrates cargo-intrinsic motifs, post-translational modifications, adaptor availability and signaling feedback. For example, membrane-proximal N-terminal residues of the dopamine transporter negatively regulate its own endocytosis, thereby controlling transporter surface levels. In parallel, the oxygen-sensing pathway can suppress endocytosis under specific conditions, linking cellular metabolism to membrane trafficking. Negative regulation of receptor tyrosine kinases through c-Cbl and receptor ubiquitylation further illustrates how endocytosis and its inhibition are interleaved with signaling. Because defects in these brakes can alter receptor half-life, immune activation and angiogenesis, GO:0045806 is relevant to cancer biology, neurobiology, immunology and vascular biology. This article synthesizes the QuickGO definition and verified PubMed literature to provide a research-grade overview of the term, its mechanisms, key genes, disease links and experimental methods, including CRISPR-based models for causal validation.
negative regulation of endocytosis At A Glance
| GO ID | GO:0045806 |
|---|---|
| GO term | negative regulation of endocytosis |
| Ontology | biological_process |
| Definition | Any process that stops, prevents, or reduces the frequency, rate or extent of endocytosis. |
| Synonym | down regulation of endocytosis; down-regulation of endocytosis; downregulation of endocytosis; inhibition of endocytosis |
| Major function | Tuning the rate and extent of endocytosis to control surface receptor levels, signaling duration and nutrient uptake. |
| Biological context | Receptor tyrosine kinase signaling, JAK-STAT signaling, T cell activation, dopamine transport, angiogenesis and iron uptake. |
| Representative regulators | Membrane-proximal N-terminal residues of cargo, oxygen-sensing pathway components, c-Cbl, Dab2, DCBLD1 and endocytic trafficking machinery. |
| Disease relevance | Cancer, immune dysregulation, metabolic and iron-related disorders, and angiogenesis-associated pathology. |
What Is GO:0045806?
GO:0045806, negative regulation of endocytosis, is defined by QuickGO as any process that stops, prevents, or reduces the frequency, rate or extent of endocytosis. In practice, this includes molecular events that block the initiation of endocytic vesicle formation, reduce the efficiency of cargo recruitment, delay vesicle scission, or promote the recycling or stabilization of surface receptors so that they are not internalized. It is a biological_process term and is not restricted to a single pathway; it can apply to clathrin-mediated endocytosis, caveolar uptake, macropinocytosis and other internalization routes. Synonyms include down regulation of endocytosis, down-regulation of endocytosis, downregulation of endocytosis and inhibition of endocytosis.
Why Is negative regulation of endocytosis Important in Cell Biology?
Negative regulation of endocytosis is important because it sets the threshold for how long and how strongly a cell responds to extracellular cues. Without these brakes, receptors such as receptor tyrosine kinases and cytokine receptors would be internalized too rapidly or too extensively, altering downstream signaling, cell proliferation and differentiation. Conversely, loss of negative regulation can stabilize surface receptors and prolong signaling, which is relevant to cancer and immune disorders. The term also connects membrane trafficking to oxygen sensing and iron uptake, showing that endocytosis control is integrated with cellular metabolism.
• Controls the surface residence time of receptors, thereby shaping the duration and amplitude of signaling.
• Regulates receptor tyrosine kinase ubiquitylation and downregulation through c-Cbl-dependent mechanisms.
• Modulates JAK-STAT signaling by altering endocytic trafficking of pathway components.
• Influences T cell activation thresholds and immune responses.
• Affects dopamine transporter surface levels and dopaminergic neurotransmission through cargo-intrinsic motifs.
• Links oxygen sensing to membrane trafficking, with implications for hypoxia-related biology.
• Contributes to angiogenesis by regulating VEGFR-2 endocytosis in endothelial cells.
• Impacts iron endocytosis and epigenetic plasticity via CD44, connecting trafficking to metabolism and gene regulation.
• Provides candidate targets for therapeutic modulation of receptor signaling in cancer and immune disease.
• Is experimentally tractable using CRISPR knockout, point mutation, knock-in and overexpression models.
What Happens During negative regulation of endocytosis?
Cargo recognition and membrane-proximal brakes
In simple terms: Some cargo proteins carry built-in signals near the membrane that tell the cell not to internalize them too quickly.
Negative regulation of endocytosis can begin at the level of the cargo itself. Membrane-proximal N-terminal residues of the dopamine transporter act as a negative regulatory element that reduces the transporter's own endocytosis, thereby maintaining its surface expression. This illustrates a general principle: intrinsic motifs within cargo proteins can set a threshold for internalization and prevent excessive removal from the plasma membrane. Such cargo-intrinsic brakes are often studied by mutating the relevant residues and measuring surface levels and uptake rates.
Oxygen-sensing and metabolic control of endocytosis
In simple terms: Cells can sense oxygen levels and use that information to slow down endocytosis when needed.
The oxygen-sensing pathway can negatively regulate endocytosis, linking cellular oxygen status to membrane trafficking. This means that under specific oxygen conditions, components of the oxygen-sensing machinery reduce the rate of endocytosis, which may help cells adapt to metabolic stress. This connection places GO:0045806 within the broader context of cellular stress responses and metabolic regulation.
Ubiquitylation and adaptor-mediated suppression
In simple terms: Tagging receptors with ubiquitin and using adaptor proteins can put the brakes on their internalization.
Negative regulation of receptor tyrosine kinases involves unexpected links to c-Cbl and receptor ubiquitylation, where ubiquitylation and adaptor availability determine whether receptors are internalized or retained at the surface. The endocytic adaptor disabled-2 (Dab2) is itself negatively regulated in mitosis, showing that the availability of adaptor proteins can be cell-cycle controlled and can indirectly suppress endocytosis. These mechanisms demonstrate that negative regulation of endocytosis operates through post-translational modification and adaptor sequestration.
Trafficking-dependent modulation of signaling
In simple terms: How a cell routes internalized proteins can change whether signaling continues or stops.
Endocytic trafficking can negatively regulate Drosophila JAK-STAT signaling, indicating that routing of receptors and ligands through endosomal compartments can attenuate signal transduction. Similarly, negative regulation of T cell activation involves control of endocytic trafficking and surface receptor dynamics. These examples show that GO:0045806 is not only about blocking uptake but also about directing internalized cargo to compartments that terminate signaling.
Vascular and iron-related endocytosis control
In simple terms: In blood vessel cells and in iron uptake, specific proteins can slow endocytosis to adjust cell behavior.
DCBLD1 modulates angiogenesis by regulating VEGFR-2 endocytosis in endothelial cells, providing a direct example of negative regulation of endocytosis in vascular biology. CD44 regulates epigenetic plasticity by mediating iron endocytosis, linking endocytic control to iron homeostasis and chromatin state. Together, these findings expand the physiological scope of GO:0045806 to angiogenesis and metabolic-epigenetic crosstalk.
Key Genes Involved in GO:0045806 negative regulation of endocytosis
The following genes and proteins have been experimentally implicated in negative regulation of endocytosis or in closely related endocytic control mechanisms, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC6A3 (DAT) | Dopamine transporter with membrane-proximal N-terminal residues that negatively regulate its own endocytosis | Cargo-intrinsic brake; surface expression and dopaminergic signaling studies |
| CBL (c-Cbl) | Ubiquitin ligase adaptor linked to negative regulation of receptor tyrosine kinases | Receptor ubiquitylation and downregulation studies |
| DAB2 | Endocytic adaptor negatively regulated in mitosis | Cell-cycle control of adaptor availability and endocytosis |
| DCBLD1 | Modulates angiogenesis by regulating VEGFR-2 endocytosis | Endothelial cell endocytosis and angiogenesis models |
| CD44 | Mediates iron endocytosis and regulates epigenetic plasticity | Iron uptake, metabolism and chromatin regulation studies |
| VEGFR-2 (KDR) | Receptor whose endocytosis is regulated by DCBLD1 in endothelial cells | Angiogenesis and receptor trafficking studies |
| JAK | Component of JAK-STAT signaling affected by endocytic trafficking | Signaling attenuation by endosomal routing |
| STAT | Transcription factor downstream of JAK, modulated by endocytic trafficking | JAK-STAT signaling and endocytosis crosstalk |
| TCR components | T cell receptor subunits whose surface dynamics are linked to negative regulation of activation | T cell activation and immune regulation studies |
| Oxygen-sensing pathway components | Mediate oxygen-dependent negative regulation of endocytosis | Hypoxia and metabolic regulation of trafficking |
| RTKs | Receptor tyrosine kinases subject to negative regulation via ubiquitylation and adaptors | Receptor downregulation and cancer signaling studies |
| Endocytic machinery proteins | General components whose availability or modification can reduce endocytosis | Mechanistic studies of vesicle formation and scission |
| Iron transport proteins | Participate in CD44-mediated iron endocytosis | Iron homeostasis and epigenetic plasticity |
| Angiogenic signaling proteins | Contribute to VEGFR-2 trafficking control | Vascular biology and endothelial cell models |
| Immune signaling proteins | Link endocytic trafficking to T cell activation thresholds | Immunology and receptor dynamics studies |
How Is negative regulation of endocytosis Regulated?
Negative regulation of endocytosis is itself regulated at multiple levels. Cargo-intrinsic motifs, such as membrane-proximal N-terminal residues of the dopamine transporter, can suppress internalization in a cell-autonomous manner. Post-translational modification, particularly ubiquitylation mediated by c-Cbl, controls receptor tyrosine kinase downregulation and thereby influences whether endocytosis proceeds. Adaptor availability is another regulatory layer: Dab2 is negatively regulated during mitosis, so cell-cycle state can change the endocytic capacity of a cell. Oxygen-sensing pathways add metabolic control, reducing endocytosis under specific oxygen conditions. Finally, signaling pathways such as JAK-STAT and T cell receptor signaling are modulated by endocytic trafficking, creating feedback loops that can further tune the rate of endocytosis.
negative regulation of endocytosis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CBL (c-Cbl) | Cancer and receptor tyrosine kinase signaling | Knockout or point-mutation cell lines with receptor downregulation assays |
| CD44 | Iron metabolism and epigenetic plasticity in cancer | Knockout and overexpression models with iron uptake and chromatin readouts |
| DCBLD1 | Angiogenesis and vascular disease | Endothelial cell knockout and overexpression models with VEGFR-2 trafficking assays |
| SLC6A3 (DAT) | Dopaminergic neurotransmission and neurological disorders | Point-mutation knock-in models of membrane-proximal N-terminal residues |
| DAB2 | Cell-cycle-related endocytic control and proliferation | Knockout and tagged knock-in models with mitotic synchronization |
Cancer and receptor signaling
Negative regulation of endocytosis controls the surface levels and signaling duration of receptor tyrosine kinases and other receptors. When these brakes are altered, receptors may remain at the surface longer, prolonging proliferative signals. c-Cbl-dependent ubiquitylation and receptor downregulation are directly linked to negative regulation of receptor tyrosine kinases, and their perturbation can contribute to oncogenic signaling. CD44-mediated iron endocytosis also connects endocytic control to epigenetic plasticity, which is relevant to tumor cell adaptation.
Immune and inflammatory disorders
Endocytic trafficking negatively regulates JAK-STAT signaling and T cell activation, meaning that defects in these brakes can lead to excessive or prolonged immune responses. Negative regulation of T cell activation involves control of surface receptor dynamics, and disruption of this control may contribute to autoimmunity or chronic inflammation. JAK-STAT signaling is similarly sensitive to endocytic routing, so altered negative regulation of endocytosis could change cytokine responsiveness.
Metabolic, iron-related and vascular pathology
CD44 mediates iron endocytosis and regulates epigenetic plasticity, linking negative regulation of endocytosis to iron homeostasis and metabolic gene expression. In endothelial cells, DCBLD1 modulates angiogenesis by regulating VEGFR-2 endocytosis, so dysregulation of this process can affect blood vessel formation. Oxygen-sensing pathways that negatively regulate endocytosis further connect this term to hypoxia-related and metabolic disease contexts.
From negative regulation of endocytosis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a candidate gene negatively regulate endocytosis? | CRISPR knockout cell line with uptake and surface-receptor assays |
| Do specific cargo residues act as negative regulatory motifs? | Point-mutation knock-in of the cargo gene |
| How does a regulator affect receptor trafficking in real time? | Tagged knock-in of the receptor or regulator with live imaging |
| Does overexpression of a regulator reduce endocytosis? | Doxycycline-inducible overexpression cell model |
| Which genes modify negative regulation of endocytosis? | Genome-wide CRISPR library screening with endocytosis readouts |
| How does oxygen or metabolic state change endocytic brakes? | Knockout models combined with hypoxia or metabolic perturbation |
How to Study the negative regulation of endocytosis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell fluorescence imaging | Rate and extent of cargo internalization | Visualizing negative regulation of endocytosis in real time |
| Surface biotinylation | Plasma membrane levels of receptors | Quantifying receptor retention or internalization |
| Ubiquitylation assays | Post-translational modification of receptors | Studying c-Cbl-dependent negative regulation |
| RNA sequencing | Transcriptional changes downstream of endocytic perturbation | Mapping signaling consequences of altered endocytosis |
| Proteomics of endosomal fractions | Protein composition of trafficking compartments | Identifying regulators and cargo |
| CRISPR library screening | Genes that modify endocytosis when perturbed | Discovery of novel negative regulators |
| Phospho-signaling assays | Activation state of signaling pathways | Linking endocytosis to JAK-STAT or T cell signaling |
| Iron uptake assays | CD44-mediated iron endocytosis | Connecting trafficking to metabolism and epigenetics |
Imaging-based endocytosis assays
Fluorescence imaging of labeled cargo, surface receptor staining and live-cell microscopy can quantify the rate and extent of endocytosis in control versus perturbed cells. Tagged knock-in models allow tracking of specific receptors or regulators, as illustrated by studies of VEGFR-2 trafficking in endothelial cells. These methods are essential for directly observing negative regulation of endocytosis at the single-cell level.
Biochemical and proteomic approaches
Surface biotinylation, receptor internalization assays and ubiquitylation analysis can measure changes in surface levels and post-translational modifications. c-Cbl-dependent receptor ubiquitylation is a classic readout for negative regulation of receptor tyrosine kinases. Proteomic profiling of endosomal fractions can identify proteins whose abundance or modification changes when negative regulation is perturbed.
Transcriptomic and signaling readouts
RNA sequencing and phospho-signaling assays can reveal downstream consequences of altered endocytosis. JAK-STAT signaling and T cell activation are sensitive to endocytic trafficking, so transcriptomic changes in these pathways can serve as functional readouts. Combining these readouts with CRISPR perturbations helps establish causality.
Genetic screening and bioinformatics
CRISPR library screening can identify genes that modify negative regulation of endocytosis when knocked out or overexpressed. Bioinformatics integration of screening hits with pathway databases and expression data helps prioritize candidate regulators for follow-up. This approach is particularly useful when the regulatory network is complex and involves multiple trafficking routes.
How CRISPR Can Be Used to Study GO:0045806 negative regulation of endocytosis
Knockout
CRISPR knockout of candidate genes is used to test whether loss of a factor increases endocytosis, which would indicate a negative regulatory role. For example, knocking out DCBLD1 or related regulators can reveal changes in VEGFR-2 endocytosis and angiogenesis-related phenotypes. Knockout of adaptor proteins such as Dab2 can also perturb cell-cycle-linked endocytic control.
Point Mutation
Point mutation is ideal for dissecting cargo-intrinsic negative regulatory motifs. Mutating membrane-proximal N-terminal residues of the dopamine transporter can abolish its negative regulation of endocytosis, directly linking specific residues to function. This approach avoids confounding effects of complete protein loss and provides mechanistic insight.
Knock-in
Knock-in of tags or reporters allows tracking of endogenous proteins during endocytosis. Tagged knock-in of receptors or regulators enables live imaging of trafficking and quantification of internalization rates in physiologically relevant contexts. Knock-in can also be used to introduce disease-associated variants that alter negative regulation of endocytosis.
Overexpression
Overexpression of a candidate negative regulator can suppress endocytosis and reduce surface receptor internalization. For instance, overexpressing DCBLD1 or CD44-related factors can modulate VEGFR-2 or iron endocytosis, respectively. Overexpression models are useful for gain-of-function studies and for validating screening hits.
How EDITGENE Supports negative regulation of endocytosis Research
Researchers studying negative regulation of endocytosis-related genes often need to determine whether a candidate gene is causally involved in suppressing endocytosis or whether it is merely correlated with trafficking changes. CRISPR-based models provide the necessary causal evidence by allowing precise knockout, point mutation, knock-in or overexpression of the gene of interest in relevant cell types.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of endocytosis research.
Frequently Asked Questions About negative regulation of endocytosis
What is GO:0045806 negative regulation of endocytosis?
GO:0045806 is a Gene Ontology biological_process term defined as any process that stops, prevents, or reduces the frequency, rate or extent of endocytosis. It includes molecular events that block or slow the internalization of surface receptors and other cargo.
What genes are involved in negative regulation of endocytosis?
Genes and proteins implicated in this process include SLC6A3 (DAT), CBL (c-Cbl), DAB2, DCBLD1, CD44, VEGFR-2, JAK, STAT and components of the oxygen-sensing pathway, based on published studies.
How does negative regulation of endocytosis control receptor signaling?
By reducing the internalization of surface receptors, negative regulation of endocytosis prolongs or shortens signaling depending on context. For example, c-Cbl-dependent ubiquitylation controls receptor tyrosine kinase downregulation, while endocytic trafficking can attenuate JAK-STAT and T cell signaling.
What is the role of membrane-proximal N-terminal residues in endocytosis?
Membrane-proximal N-terminal residues of the dopamine transporter act as a negative regulatory element that reduces its own endocytosis, helping maintain surface expression.
How is oxygen sensing linked to negative regulation of endocytosis?
The oxygen-sensing pathway can negatively regulate endocytosis, connecting cellular oxygen status to membrane trafficking and metabolic adaptation.
Which diseases are associated with altered negative regulation of endocytosis?
Altered negative regulation of endocytosis has been linked to cancer, immune dysregulation, angiogenesis-related pathology and iron metabolism disorders, through genes such as CBL, CD44, DCBLD1 and SLC6A3.
What experimental models are used to study negative regulation of endocytosis?
Common models include CRISPR knockout, point-mutation, knock-in, tagged knock-in and overexpression cell lines, combined with imaging, biochemical and omics readouts.
How does CD44 relate to endocytosis and epigenetics?
CD44 mediates iron endocytosis and regulates epigenetic plasticity, linking endocytic control to iron homeostasis and chromatin state.
What is the role of DCBLD1 in endocytosis?
DCBLD1 modulates angiogenesis by regulating VEGFR-2 endocytosis in endothelial cells, providing a vascular example of negative regulation of endocytosis.
How can CRISPR screening help identify negative regulators of endocytosis?
CRISPR library screening can systematically perturb genes and measure endocytosis readouts, revealing novel negative regulators that can then be validated with knockout or overexpression models.
Conclusion
GO:0045806, negative regulation of endocytosis, captures a critical layer of cellular control that determines how long receptors, transporters and nutrients remain at the cell surface. The verified literature shows that this regulation operates through cargo-intrinsic motifs, ubiquitylation and adaptor proteins, oxygen-sensing pathways and trafficking-dependent signaling modulation. Its dysfunction is linked to cancer, immune disorders, angiogenesis and metabolic pathology, making it a high-value area for mechanistic and translational research. CRISPR-based knockout, point-mutation, knock-in and overexpression models, combined with imaging, proteomics and screening approaches, provide the tools needed to establish causality and map the regulatory network of negative regulation of endocytosis. EDITGENE supports these efforts with custom cell model generation, library screening and bioinformatics services tailored to endocytosis research.
References
- 1. Müller S et al.. 2020. CD44 regulates epigenetic plasticity by mediating iron endocytosis.. Nat Chem 12(10):929-938 PMID: 32747755
- 2. Sorkina T et al.. 2009. Negative regulation of dopamine transporter endocytosis by membrane-proximal N-terminal residues.. J Neurosci 29(5):1361-74 PMID: 19193883
- 3. Wang Y et al.. 2009. Regulation of endocytosis via the oxygen-sensing pathway.. Nat Med 15(3):319-24 PMID: 19252501
- 4. Rubin C et al.. 2005. Negative regulation of receptor tyrosine kinases: unexpected links to c-Cbl and receptor ubiquitylation.. Cell Res 15(1):66-71 PMID: 15686631
- 5. Chetrit D et al.. 2011. Negative regulation of the endocytic adaptor disabled-2 (Dab2) in mitosis.. J Biol Chem 286(7):5392-403 PMID: 21097498
- 6. Feng Q et al.. 2025. DCBLD1 Modulates Angiogenesis by Regulation of the VEGFR-2 Endocytosis in Endothelial Cells.. Arterioscler Thromb Vasc Biol 45(2):198-217 PMID: 39665138
- 7. Vidal OM et al.. 2010. Negative regulation of Drosophila JAK-STAT signalling by endocytic trafficking.. J Cell Sci 123(Pt 20):3457-66 PMID: 20841381
- 8. Saito T. 1998. Negative regulation of T cell activation.. Curr Opin Immunol 10(3):313-21 PMID: 9638368
